Maravai LifeSciences Holdings, Inc. Operating Lease Cost
Maravai LifeSciences Holdings, Inc. (MRVI) reported Operating Lease Cost of $12.11 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. operating lease, cost for the quarter ending 2023-12-31 was $3.12M, a 22.08% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, cost for the quarter ending 2023-09-30 was $3.12M, a 25.85% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, cost for the quarter ending 2023-06-30 was $3.12M, a 64.90% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, cost for the quarter ending 2023-03-31 was $3.06M, a 63.18% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. operating lease, cost for fiscal 2025 was $12.11M, a 0.87% increase from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. operating lease, cost for fiscal 2024 was $12.00M, a 3.33% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. operating lease, cost for fiscal 2023 was $12.42M, a 41.10% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. operating lease, cost for fiscal 2022 was $8.80M, a 0.09% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.11M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $12.00M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.24M derived: sum of 2 quarters · filed 2026-02-26 | $9.36M derived: sum of 3 quarters · filed 2026-02-26 | $12.42M 10-K · filed 2026-02-26 |
| 2023-09-30 | $3.12M 10-Q · filed 2023-11-08 | $6.24M derived: sum of 2 quarters · filed 2023-11-08 | $9.30M 10-Q · filed 2023-11-08 | $11.85M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-06-30 | $3.12M 10-Q · filed 2023-08-08 | $6.18M 10-Q · filed 2023-08-08 | $8.73M derived: sum of 3 quarters · filed 2025-03-18 | $11.21M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-03-31 | $3.06M 10-Q · filed 2023-05-09 | $5.61M derived: sum of 2 quarters · filed 2025-03-18 | $8.09M derived: sum of 3 quarters · filed 2025-03-18 | $9.98M derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $5.03M derived: sum of 2 quarters · filed 2025-03-18 | $6.93M derived: sum of 3 quarters · filed 2025-03-18 | $8.80M 10-K · filed 2025-03-18 |
| 2022-09-30 | $2.48M 10-Q · filed 2023-11-08 | $4.37M derived: sum of 2 quarters · filed 2023-11-08 | $6.25M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.89M 10-Q · filed 2023-08-08 | $3.77M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $1.87M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $8.79M 10-K · filed 2024-02-29 |